Dose Individualization of Cefepime for Febrile Neutropenia in Patients With Lymphoma or Multiple Myeloma: Implications for Therapeutic Drug Monitoring.

Oda, Kazutaka; Yamaguchi, Ayami; Matsumoto, Naoya; Nakata, Hirotomo; Higuchi, Yusuke; Nosaka, Kisato; Jono, Hirofumi; Saito, Hideyuki

Oda, Kazutaka; Yamaguchi, Ayami; Matsumoto, Naoya; Nakata, Hirotomo; Higuchi, Yusuke; Nosaka, Kisato; Jono, Hirofumi; Saito, Hideyuki.

Afiliación

Oda K; Departments of Pharmacy and.
Yamaguchi A; Infection Control, Kumamoto University Hospital, Chuo-ku, Kumamoto, Japan; and.
Matsumoto N; Department of Clinical Pharmaceutical Sciences, Graduate School of Pharmaceutical Sciences, Kumamoto University, Chuo-ku, Kumamoto, Japan.
Nakata H; Department of Clinical Pharmaceutical Sciences, Graduate School of Pharmaceutical Sciences, Kumamoto University, Chuo-ku, Kumamoto, Japan.
Higuchi Y; Infection Control, Kumamoto University Hospital, Chuo-ku, Kumamoto, Japan; and.
Nosaka K; Infection Control, Kumamoto University Hospital, Chuo-ku, Kumamoto, Japan; and.
Jono H; Infection Control, Kumamoto University Hospital, Chuo-ku, Kumamoto, Japan; and.
Saito H; Departments of Pharmacy and.

Ther Drug Monit ; 46(1): 80-88, 2024 02 01.

Article en En | MEDLINE | ID: mdl-37735762

Asunto(s)

Neutropenia Febril; Linfoma; Mieloma Múltiple; Humanos; Cefepima; Antibacterianos/farmacocinética; Mieloma Múltiple/complicaciones; Mieloma Múltiple/tratamiento farmacológico; Estudios Prospectivos; Teorema de Bayes; Monitoreo de Drogas; Pruebas de Sensibilidad Microbiana; Neutropenia Febril/tratamiento farmacológico

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neutropenia Febril / Linfoma / Mieloma Múltiple Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Ther Drug Monit Año: 2024 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google